- 12 oral surgery updates in 2026
- 5 ASC, MOB deals in California
- Hidden OR capacity challenges: 8 perioperative leaders on what’s draining surgical time
- The Aspen Group’s 3-year growth recap: 40 moves
- Florida State University set to acquire Tallahassee hospital
- How Confusing Financial Journeys Undermine Revenue and Trust
- How Confusing Financial Journeys Undermine Revenue and Trust
- Misalignment, Not Malice: Rethinking Generational Conflict in Healthcare
- If AI ‘adds friction, it fails’: How Mayo Clinic scales technology
- As maternity units close, AdventHealth restores OB care in rural Kansas
- Oklahoma officials warn of new opioid
- The new metrics of healthcare technology ROI: What matters to healthcare leaders
- Hoag to launch transplant center in 2027
- MercyOne hospital to transition labor and delivery services
- MercyOne hospital to transition labor and delivery services
- Southeast metros lead US population growth as national gains slow
- 8 Medicare Advantage numbers to know in 2026
- 17 Senate Dems push back on 2027 ACA proposal
- Providence hospital closes inpatient pediatric unit
- Michigan finalizes Medicaid mental health assessment policy changes
- 10 financial notes on USPI’s growth over the past 3 years
- 15 new orthopedic practice, center openings in Q1
- The oral surgery technological revolution
- From Anxiety to Action: How Ambulatory Leaders Are Rebuilding Margins in 2026
- Where GI training may fall short
- What it took to become the world’s first ASC to offer Stryker’s robotic knee tech
- Medtronic’s win in spinal cord stimulator lawsuit upheld
- How the Trump Administration Uses Migrant Kids To Find and Detain Family Members
- Heartland Dental’s 3-year growth recap: 30+ moves
- Cencora’s $10B+ physician acquisition spree: A breakdown
- Tennessee physician practice acquired
- The FTC is coming for healthcare consolidation: 10 things physicians need to know
- Adventist Health sees momentum from insourcing revenue cycle operations
- Oral GLP-1s, COVID preventatives: 3 more drugs in the pipeline, Optum says payers should watch
- Unlicensed dentistry cases, DSO deals, legislation & more: 10 dentistry updates in Virginia
- Missouri system debuts mobile behavioral health unit
- Yale researchers study GLP-1’s potential for SUD
- Texas dental school receives $6.5M to expand pediatric dental, medical programs
- North Carolina autism provider to expand therapy access
- $3M Verdict Links Social Media to Anxiety and Depression
- West Virginia hospital to end OB delivery services
- 6 DSOs making headlines
- California hospital’s finances improve, cash position remains ‘dire’
- 1 in 5 metro markets face inpatient monopoly: 7 notes
- Minnesota system faces uncertainty amid Medicare delays
- Ohio county approves behavioral health crisis center plan
- The White House Delays CDC Pick
- New COVID 'Cicada' Variant Is Spreading — What Experts Want You To Know
- Op-ed: Empathy meets efficiency—how the responsible use of AI can transform Medicare
- Family Caregivers Provide $1 Trillion In Annual Labor, AARP Says
- ‘Health Doesn’t Need to Be Ludacris’: Bayer signs rapper-actor to multivitamin campaign
- Rocket plots measured trajectory for new gene therapy Kresladi after clearance to launch from FDA
- Healthy Lab Results May Mask Future Risks for Kids with Obesity
- At-Home Chemotherapy Is Safe, Feasible, Pilot Study Indicates
- What You Do While Sitting Could Predict Dementia Risk
- New Cholesterol Guidelines: What Patients and Caregivers Need to Know
- Want A Bootlicking Yes Man? Ask An AI Chatbot For Advice, Study Warns
- Specially Coated Implants Better For Breast Cancer Patients, Study Finds
- Trump Team Claims Successes Against ACA Fraud While Pushing for More Controls
- Give and Take: Federal Rural Health Funding Could Trigger Service Cuts
- Fierce Pharma Asia—Takeda’s $1.3B reorg; India’s GLP-1 floodgates; Gilead’s $2.2B buy of a China NewCo
- Where are you with EUDAMED?
- Where are you with EUDAMED?
- HL7 Launches Real‑Time Medical Device Interoperability Accelerator
- HL7 Launches Real‑Time Medical Device Interoperability Accelerator
- Two GA Tech ATDC Startups — Nephrodite and OrthoPreserve — Secure FDA Breakthrough Device Designation
- Two GA Tech ATDC Startups — Nephrodite and OrthoPreserve — Secure FDA Breakthrough Device Designation
- Artificial Intelligence: ROI, not Clinical Autonomy, Leads Operational Workflows
- Artificial Intelligence: ROI, not Clinical Autonomy, Leads Operational Workflows
- Medtronic and Merit Medical Systems distribution agreement for new, ViaVerte basivertebral nerve ablation system
- Medtronic and Merit Medical Systems distribution agreement for new, ViaVerte basivertebral nerve ablation system
- Breakthrough Device Designation for Noah Labs Vox Heart Failure Detection Device
- Breakthrough Device Designation for Noah Labs Vox Heart Failure Detection Device
- Why private practice dentistry needs a better model
- CareQuest Innovation Partners, Kno2 collab on medical-dental data integration
- Nonprofit highlights rural opioid care strategies
- Vitana Pediatric & Orthodontic Partners adds Florida practice
- What the Health? From KFF Health News: A Headless CDC
- 20 behavioral health leaders challenge industry assumptions
- Recordati confirms it's weighing CVC Capital buyout offer of $12.6B
- 3 California behavioral health centers to close amid funding shifts
- Indiana bars autism therapy provider from Medicaid billing: Wall Street Journal
- UnitedHealth shareholder sues over proposal to include details on integration in annual proxy
- SCAN taps biopharma, CMS vet Aman Bhandari as its first chief AI officer
- Infosys to acquire Optimum Healthcare IT in $465M deal
- DOJ alleges NewYork-Presbyterian forces payers into anticompetitive 'all-or-nothing' contracts
- FDA Warns Biotech Firm Over Cancer Drug Anktiva Claims
- Bees and Hummingbirds May Be Consuming Small Amounts of Alcohol
- Two States Sue Cord Blood Company Over Misleading Claims
- New WHO Guidance Aims To Speed Tuberculosis Testing
- As questions swirl around ATTR competition, Alnylam plots path to market leadership for Amvuttra
- Trump admin delays nomination for new CDC director past deadline
- Outspoken ACIP member steps down amid vaccine panel uncertainty: reports
- Egg-based drugmaker Neion Bio emerges from stealth to cook up multi-product biosimilar collab
- Genentech walks the walk in lupus as sponsor of annual awareness and fundraising event
- Study Reveals How Many Americans Consider Using a Gun
- Massive Study Finds Stress and Grief Don’t Cause Cancer
- Ultra-Processed Foods Harm Fertility In Both Men And Women, Studies Reveal
- Small Daily Habits Can Add Up To Better Heart Health
- Ritalin Might Protect ADHD Kids' Long-Term Mental Health, Study Finds
- Can You Drink Enough Fluids To Prevent Kidney Stones? Maybe Not, New Study Says
- Clasp, loan-linked hiring tool for employers, clinches $20M to expand amid federal loan caps
- Taking a GLP-1? Doctors Say Not To Forget About Movement and Mental Health
- OpenEvidence rolls out AI medical coding feature
- CDC’s Acting Chief Promises a Return to Stability in a Tumultuous Moment
- Remarks at the Financial Stability Oversight Council Meeting
- RWJF: Between 5M and 10M people could lose Medicaid coverage in 2028 under work requirements
- New therapy animal program aims to support 100K patients, providers
- Pulse check on Lilly's GLP-1 fortunes
- Gen Z nurses prioritize schedule flexibility, need more manager interactions to avoid turnover
- How pharma marketers can capitalize on HCPs’ AI, social media and streaming habits
- Federal Officials Investigate States That Require Abortion Coverage
- Corcept's lead drug bounces back from FDA snub with different approval as Lifyorli in ovarian cancer
- Ionis slashes Tryngolza's price tag by 93% ahead of anticipated label expansion
- FDA approves Denali's Hunter syndrome drug, handing rare disease community a win
- Baby Walkers Sold on Amazon Recalled Over Fall Risk
- Want To Protect Your Brain? Science Says Exercise
- HelloFresh Pizza Recall Issued in 10 States Over Metal Risk
- Clinical Trials Have Too Much Data…That’s the Problem.
- Clinical Trials Have Too Much Data…That’s the Problem.
- CMS reveals new Medicaid model that supports coordination for children with complex needs
- Novartis sued by breast cancer patient over branded drug websites’ data-sharing practices
- Takeda targets $1.3B in cost savings in further restructuring
- Biogen pays $20M upfront to tap into Alteogen's subQ delivery tech
- 'Universal Donor' Blood Supplies Dangerously Low, Study Warns
- Why Stepping Outside May Help You Eat Better
- U.S. Medicine, Science Facing An Online Misinformation Siege, Poll Concludes
- Childhood Obesity Undercuts The American Dream For Some, Study Says
- Inclusive High Schools Benefit All Students, Not Just LGBTQ Teens
- Parental Loss Due to Drugs, Violence Raises Child Death Risk by 2,000%
- As Boehringer touts US launches, board chairman worries EU is 'falling further behind'
- The evolving state of exome and genome sequencing
- Demoralized CDC Workforce Reels From Year of Firings, Funding Cuts, and a Shooting
- An Arm and a Leg: Steep Health Care Costs Steer Americans to Tough Decisions
- Qualified Health locks in $125M in fresh funding to scale enterprise AI at health systems
- Misery Loves [Investment] Company?: Remarks at the 2026 Investment Company Institute Investment Management Conference
- Study: Nearly 1 in 5 pediatric hospital deaths involve sepsis
- As expansions come online, CDMO Hovione aims to meet industry's 'dual supply and sourcing' zeal: exec
- Opening Remarks at the Digital Asset Summit 2026
- CVS Caremark, FTC reach settlement in insulin pricing case
- UCB unveils plan to build $2B biologics plant near its US headquarters in Atlanta
- PeaceHealth sued over plans to tap out-of-state staffer ApolloMD for Oregon EDs
- New Lyme Disease Vaccine Shows Strong Results in Trial
- TrumpRx Adds Diabetes, COPD Drugs at Steep Discounts
- Highmark reports $175M net loss for 2025 as financial headwinds batter health plan
- Listen to the Latest ‘KFF Health News Minute’
- Abivax hires commercial chief from Takeda to infuse Entyvio expertise into IBD launch prep
- ImmunityBio hit with FDA warning letter over Anktiva promotions in TV ad, podcast episode
- Alcohol Prep Pads Recalled Over Bacteria Risk, Cardinal Health Says
- Fewer patients traveled for abortions in 2025 as telehealth care increased, report finds
Make Michigan New York
House Democrats continue to advance vexsome regulations in their concerted effort to depopulate Michigan. HB 5250, the Weight Loss Products and Minors Act, will establish health supplement controls. An idea imported from the growth control experts over in New York State:
https://legislature.mi.gov/Bills/Bill?ObjectName=2025-HB-5250
Photo ID for diet pills? Michigan bill would ban supplements for minors
By Eli Newman - December 2, 2025
- A Michigan House bill would impose new photo ID requirements to purchase weight loss and muscle-building supplements, blocking sales to anyone younger than 18 and requiring retailers to keep products out of reach
- Public health researchers say the supplements’ use by minors is a “gateway behavior” linked to eating disorders and steroid use and may cause other health problems
- Dietary supplement lobbyists oppose the legislation, arguing it could restrict access for all customers while harming Michigan’s $1.8 billion dietary supplement industry
Michigan retailers selling weight loss and muscle-building supplements would need to verify a customer’s age by photo identification before approving sales under a recently introduced bill in the state House.
The proposed legislation would stop those younger than 18 from purchasing over-the-counter diet pills in person and online, extending ID requirements to products containing creatine, green tea extract, raspberry ketone, garcinia cambogia and coffee bean extract.
State Rep. Erin Byrnes, D-Dearborn, introduced the bill last month, saying today’s youth face a “constant barrage” of advertising and social media content that promotes “impossible to meet” body goals. The law, she said, would protect “vulnerable” minors from the supplement companies who work to “encourage and then capitalize” on their low self-esteem.
“Unrealistic narrow body image standards are designed to fuel insecurities and ultimately sell products that will supposedly lead someone to attain these false standards,” Byrnes said in a news conference last month. “Our federal regulatory framework for these companies has not caught up to the modern dangers that our kids face.”
Researchers, meanwhile, said use of the supplements is linked to eating disorders and steroid use.
Steve Mister, the president and CEO of The Council for Responsible Nutrition, a trade association representing dietary supplement manufacturers and suppliers, said the bill is going after an “easy scapegoat” for young people’s eating disorders.
“These products are legal dietary supplements,” Mister told Bridge Michigan. “They are subject to federal laws and regulations and they are safe products. There is nothing to show that when somebody is using one of these products that they are more likely to have an eating disorder because of the product.”
The proposed Weight Loss Products and Minors Act, which has been referred to the state House Committee on Health Policy, would require retailers to place their products in a locked case or out of reach of the general public and impose fines on those who violate the law.
‘Gateway behavior’
Public health researchers and registered dieticians from across the state joined the Dearborn Democrat’s call for tighter regulation around supplements and heightened awareness that their use may be a warning sign for eating disorders.
“These products are linked with serious risks for young people,” Vivienne Hazzard, an assistant professor at the Michigan State University College of Medicine, said during the November press conference.
Female adolescents who use diet pills were four times more likely to be diagnosed with a first-time eating disorder than their peers who do not, according to a five-year longitudinal study conducted by Hazzard. Other studies with larger sample sizes have made similar findings.
“While we cannot say from these studies that diet pills cause eating disorders, they suggest that diet pill use is an early warning sign and may serve as a gateway behavior, setting youth on a path toward serious eating disorders,” Hazzard said.
One study that Hazzard co-authored found adolescent protein powder consumption was tied with future steroid use. She said the available public health research indicates a “consistent pattern” that weight loss and muscle-building supplement use in minors predicts later harm.
The American Academy of Pediatrics discourages the use of diet pills and cautions of the “adverse effects” of taking supplements.
Samantha Hahn, assistant professor of population health research at Central Michigan University, joined Hazzard and Byrnes to support the legislation, saying she recently completed research that found widespread use of “unregulated muscle-building substance” among high school students in the state.
“One in three of our adolescents in rural Michigan are using harmful products that are widely available on store shelves,” Hahn said. “Widespread use and easy access to diet pills and muscle-building products has mistakenly led youth to believe these products are safe.”
Out of Kids’ Hands
Michigan is the latest state to join a nationwide effort to ban the sale of over-the-counter diet pills and muscle-building supplements to minors.
At least eight other states have seen prohibition campaigns mounted by the Strategic Training Initiative for the Prevention of Eating Disorders, or STRIPED, run by the Harvard T.H. Chan School of Public Health and Boston Children’s Hospital.
New York saw its Out of Kids’ Hands legislation go into effect in 2024, a decision lauded by STRIPED Director Dr. S. Bryn Austin as a “commonsense measure to put the health and mental health of young people first.”
Aside from its correlation with eating disorders, the Harvard group cites the prevalence of tainted supplements and increased risk for severe medical events as reasons to enhance oversight over the dietary supplement industry. Currently, the US Food and Drug Administration lacks the authority to test or approve the products before they become available to consumers.
The Council for Responsible Nutrition is working to stop STRIPED’s efforts. The lobbying group asked the US Court of Appeals for the Second Circuit on Monday to rehear its case attempting to block New York’s law from going into effect.
While designed to stop minors, Mister said Michigan’s proposed legislation would end up “restricting access to everybody” as retailers adjust to the regulation, potentially curbing a customer’s ability to buy multivitamins, probiotics and prenatal vitamins because of the legislation’s phrasing.
House Bill 5250 allows the state to consider marketing and labeling to determine if a product falls under the statute, including products that purport to “modify, maintain, or reduce body weight, fat, appetite, overall metabolism, or the process by which nutrients are metabolized.”
Mister said it becomes a First Amendment rights issue if the state bases its restrictions on a product’s “factually true” claims.
“Mom and pop local retailers, the local vitamin stores, the health food stores … they will see a reduction in sales,” he said.
More than 8,500 Michigan jobs are connected to the dietary supplement industry, according to the Council for Responsible Nutrition, accounting for $1.8 billion in direct economic impact statewide. The association points to Amway, headquartered in Ada, and Perrigo in Grand Rapids as major supplement manufacturers in the state.
Bills seeking to further regulate the weight loss and muscle-building supplement market rarely make it to the governor’s desk, according to Mister. In 2024, Byrnes introduced similar legislation that did not make it out of committee.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.

















